EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review)

Zhengqi Guo, Xiaoci Li, Pengyu Suo, Zhanyu Lin, Ruixin Liu, Chenyu Chi

Oncology Reports · 26.05.2026 · 56 (1) · 1-16

DOI: 10.3892/or.2026.9141 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 26.05.2026. Verfasst von Zhengqi Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250000, P.R. China. Hauptthemen laut MEDLINE: Abietanes, Lung Neoplasms, Antineoplastic Agents, Phytogenic, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer (LC) remains a leading cause of cancer-related morbidity and mortality worldwide, with non-small cell lung cancer (NSCLC) comprising ~85% of cases.Although therapeutic options have expanded in recent years, drug resistance and tumor relapse continue to limit durable responses, highlighting the need for novel treatment strategies and effective adjuvant agents.Tanshinones are major bioactive diterpenoid quinones derived from Salvia miltiorrhiza (Danshen) and exhibit diverse pharmacological activities, including anti-inflammatory, anti-angiogenic, and antitumor effects.Growing evidence indicates that tanshinones suppress LC progression through multi-level regulation of cancer hallmarks, including inhibition of proliferation, induction of apoptosis, attenuation of invasion and metastasis, and modulation of antitumor immunity.Notably, tanshinones have also shown promise as sensitizers in combination regimens, where they enhance the efficacy of standard anticancer agents and may help overcome acquired resistance in LC models.In the present review, current mechanistic evidence on tanshinone-mediated anticancer actions in LC was synthesized and opportunities and challenges for clinical translation are examined, with the aim of informing the development of tanshinone-based therapeutic strategies and next-generation derivatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesLung NeoplasmsAntineoplastic Agents, PhytogenicCarcinoma, Non-Small-Cell LungHumansApoptosisAnimalsCell ProliferationDrug Resistance, NeoplasmSalvia miltiorrhiza

Stichwörter der Autor:innen

immune modulationlung cancermolecular mechanismsnon‑small cell lung cancertanshinones

Substanzen

AbietanestanshinoneAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • College of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250000, P.R. China.
  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250000, P.R. China.
  • Emergency and Critical Care Medicine Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250000, P.R. China.

Zitieren

APA

Guo, Z., Li, X., Suo, P., Lin, Z., Liu, R., & Chi, C. (2026). Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review). Oncology Reports, 56(1), 1-16. https://doi.org/10.3892/or.2026.9141

Vancouver

Guo Z, Li X, Suo P, Lin Z, Liu R, Chi C. Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review). Oncology Reports. 2026;56(1):1-16. doi:10.3892/or.2026.9141

BibTeX
@article{Guo2026,
  author = {Guo, Zhengqi and Li, Xiaoci and Suo, Pengyu and Lin, Zhanyu and Liu, Ruixin and Chi, Chenyu},
  title = {Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review)},
  journal = {Oncology Reports},
  year = {2026},
  volume = {56},
  number = {1},
  pages = {1--16},
  doi = {10.3892/or.2026.9141}
}
Kostenlos starten →